title: Development of Ascaris lumbricoides eggs from females eliminated after chemotherapy in man.
abstract: The development of Ascaris lumbricoides eggs obtained from females eliminated after treatment of infected individuals with a single oral dose of the antihelminthic drugs thiabendazole (50 mg/kg--33 patients) or levamisole (250 mg--independent of body weight--20 patients) was studied. Every female eliminated up to 72 h after treatment were dissected, the uterus isolated and sectioned into small fragments. The eggs were transferred to plastics tubes and incubated at 28 degrees C in 0.1 N H2SO4 for 100 days. Every 20 days, starting from the 20 th up to the 100 th day, the extent of egg embryonation ratio was determined. The culture of A. lumbricoides eggs obtained from females from patients treated with thiabendazole did not contain embryonated eggs until the final period of observation. In contrast, the eggs obtained from females eliminated by patients treated with levamisole (control) presented an embryonation rate of 0.0-98.0% in the same period.
authors.affiliation: Centro de Pesquisas René Rachou-FIOCRUZ, Belo Horizonte, MG, Brasil.
authors.forename: O S
authors.initials: OS
authors.lastname: Carvalho
authors.forename: H L
authors.initials: HL
authors.lastname: Guerra
authors.forename: C L
authors.initials: CL
authors.lastname: Massara
mesh_terms: D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D000818:Animals; D001196:Ascariasis / Q000188:drug therapy*; D001200:Ascaris / Q000302:isolation & purification / Q000502:physiology*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007978:Levamisole / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D013827:Thiabendazole / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D007978:Levamisole; D013827:Thiabendazole